RX-3117
RX-3117 is a novel fluorocyclopentenylcytosine analog with demonstrated anticancer activity in vitro against various cancer cell lines, including those resistant to gemcitabine. Research applications include investigating its mechanism and efficacy in preclinical in vivo models for oncology.
Product Specifications
CAS Number
865838-26-2
Product Name Alternative
TV1360, TV-1360, TV 1360, RX 3117, RX3117, RX-3117, S phase, DNMT1, apoptosis, antiproliferative, anti-tumour, Analog, fluorocyclopentenylcytosine, Inhibitor, inhibit, NucleosideAntimetabolite, Nucleoside Antimetabolite/Analog, Nucleoside Antimetabolite, orally active
Field of Research
Cell Biology, Molecular Biology
Purity
97.46% (May vary between batches)
Solubility
DMSO:50 mg/mL (194.39 mM)
Smiles
Nc1ccn ([C@H]2[C@H] (O) [C@H] (O) C (CO) =C2F) c (=O) n1
Molecular Formula
C10H12FN3O4
Molecular Weight
257.22
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog